Shares of Cardiff Oncology Inc. (traded on the NASDAQ Global Market under the ticker symbol CRDF) exchange hands at approximately $1.02 per share. Intraday equity valuations shift continuously during market hours in response to micro-cap biotechnology sector sentiment, clinical trial milestone announcements, and quarterly financial report filings.